MORGAN STANLEY - 30 Nov 2025 SCHEDULE 13G/A Report for Evoke Pharma Inc Common Stock (EVOK)

Filing Manager
MORGAN STANLEY
Reporting Manager
Morgan Stanley
Security
Evoke Pharma Inc Common Stock
Symbol
EVOK
Disclosed Ownership
31 shares
Ownership
0%
Form type
SCHEDULE 13G/A
Filing time
05 Dec 2025, 16:03:43 UTC
Date of event
30 Nov 2025
Previous filing
08 Sep 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Morgan Stanley 0% 31 0 0 Chris O'Hara Authorized Signatory, Morgan Stanley
Morgan Stanley Smith Barney LLC 0% 31 0 0 David Galasso Authorized Signatory, Morgan Stanley Smith Barney LLC